News

One of nation’s top heart hospitals rolls out web-based cardiac information system Perminova, developer of a new breed of web-based information systems for the nation’s leading cardiology centers, announced that Mount Sinai Medical Center in...

CHICAGO – Patients with infective endocarditis involving implanted cardiac devices experience a high rate of complications such as valve infections, heart failure, and persistent bacteremia, and high in-hospital and 1-year mortality rates,...

Bayer Inc. Welcomes Support for Public Reimbursement of New Treatment Hundreds of thousands of Canadians living with atrial fibrillation (AF) are now one step closer to getting public reimbursement for a new stroke prevention therapy — news...

Sign Against Stroke Campaign launched at World Heart Federation’s World Congress of Cardiology; calls for 1.7 million voices to unite to improve the care and treatment of atrial fibrillation, which increases stroke risk by 500...

* Builds Upon Existing Alliance and Allows Both Companies to Offer a Comprehensive Cardiovascular Portfolio to U.S. Customers * Abbott to Distribute St. Jude Medical FFR Lesion Assessment and OCT Imaging Systems Abbott and St. Jude...

Trial is intended to evaluate safety and efficacy of the new Accent MRI Pacemaker and Tendril MRI Lead to accommodate MRI scans that are often necessary in the diagnosis and evaluation of certain conditions St. Jude Medical, Inc., a global...

A new retrospective sub-analysis of the 18,113 patient RE-LY® trial showed lower rates of intracranial hemorrhage (ICH), including both fatal and traumatic ICH, for Pradaxa® (dabigatran etexilate mesylate) capsules 150mg taken twice daily...

Stryker’s Sustainability Solutions division, a leader in medical device reprocessing, introduced Restep®, the company’s pioneering deep vein thrombosis (DVT) solution. Restep addresses a critical need in the market for comprehensive device...

Design of new Ellipse ICD inspired by feedback from over 200 physicians from around the world St. Jude Medical, Inc., a global medical device company, announced CE Mark Approval of the Ellipse™ implantable cardioverter defibrillator (ICD)....

Access Point Technologies USA announced CE approval and launch of their full line of Map-iT™ diagnostic and ablation catheters in Europe. The APT Map-iT™ catheters incorporate unique shaft and handle technologies that give the doctors...